When glioma cells stimulated with serum or EGF, GSK-3β was regulated through its localized inhibition, characterized by the increased phosphorylation at the Ser9 of GSK-3β (pSer9-GSK-3β) at the leading edge of migrating glioma cells. This evidence concerns the gene EGF and central nervous system cancer.